人类多巴胺载体与可卡因复合的结构
Jeppe C Nielsen1, Kristine Salomon1, Iris E Kalenderoglou1
1Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
研究人员发现了与可卡因结合的人类多巴胺载体 (DAT) 的分子结构. 这揭示了可卡因如何抑制DAT,
科学领域:
- 神经科学
- 结构生物学
- 药理学
背景情况:
- 多巴胺转运体 (DAT) 调节多巴胺信号传递并调节可卡因的奖励效应.
- DAT属于神经递质同载体家族,利用Na+梯度进行多巴胺传输.
- 没有完全了解可卡因的传输机制和抑制DAT的作用.
研究的目的:
- 确定与可卡因复合的人类DAT的分子结构.
- 在分子层面阐明可卡因抑制机制.
- 为开发有针对性的成治疗提供基础.
主要方法:
- 使用X射线结晶学来确定人类DAT的结构.
- 该结构的分辨率为2.66 Å.
- 这项研究重点是DAT和可卡因之间的相互作用.
主要成果:
- 结构显示人体DAT与LeuT折叠的外开形状.
- 在DAT的中央 (S1) 位点观察到可卡因结合.
- 一个Na+离子占据了Na2位点,而Na1位点似乎空,而Asn82侧链占据了空间.
结论:
- 确定的结构阐明了可卡因抑制人类DAT的机制.
- 这种结构洞察力加深了对神经递质运输的理解.
- 这些发现为开发抗毒新药奠定了基础.
更多相关视频
11:26Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake
Published on: September 21, 2017
07:56A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Abuse and Addiction: Pharmacological Phenomena
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Synthesis
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
